Payments to Acquire Property, Plant, and Equipment of Keros Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Keros Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Keros Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $565,000, a 40% decline year-over-year.
  • Keros Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $1,551,000, a 20% decline from 2024.
  • Keros Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $1,931,000, a 22% decline from 2023.
  • Keros Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $2,464,000, a 99% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Keros Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,551,000 -$380,000 -20% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $1,931,000 -$533,000 -22% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $2,464,000 +$1,223,000 +99% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
2022 $1,241,000 +$217,000 +21% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $1,024,000 +$730,000 +248% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $294,000 +$23,000 +8.5% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2022 2021 FY
2019 $271,000 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY

Keros Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $565,000 -$381,000 -40% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $946,000 -$116,000 -11% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $1,062,000 +$915,000 +622% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $147,000 -$63,000 -30% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $210,000 +$34,000 +19% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2021 Q1
Q1 2020 $176,000 +$176,000 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $0 01 Jan 2019 31 Mar 2019 10-Q 22 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.